Clinical trial
Pioglitazone to Treat Fatty Liver in People With HIV Infection
NCT00441272 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00441272 |
|---|---|
| Title | Pioglitazone to Treat Fatty Liver in People With HIV Infection |
| Official title | Pioglitazone for Hepatic Steatosis in HIV |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Hepatic Steatosis, Insulin Resistance |
| Intervention type | Drug |
| Interventions | Pioglitazone |
| Enrollment | 100 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2008 |
| First posted | Feb 28, 2007 |
| Last update posted | Feb 19, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: